NIH-funded research R01 grant

Reducing lipid oxidative damage to prevent age-related muscle loss

Official title: LOOH-induced muscle atrophy with age

Funded at Utah State Higher Education System--University of Utah · NIH-11242061 · Data updated 2026-11-12

This project explores whether clearing harmful lipid oxidation products and stopping their formation could protect muscles from age-related wasting.

More Muscle Atrophy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah
NIH-funded
Lab location1 site (Salt Lake City, United States)
Project startFebruary 1, 2022
Project endNovember 30, 2026
Funding year2026
Award (this year)$531,944
NIH project number5R01AG074535-05
Project IDNIH-11242061 on NIH RePORTER

Who could benefit from this research

Could help

Older adults experiencing age-related muscle weakness or loss (sarcopenia), particularly those with reduced mobility, would be the most likely future candidates.

Less likely to help

People whose muscle loss is caused by genetic neuromuscular diseases, acute injury, or non-aging illnesses may not benefit from these lipid-focused approaches.

What this research studies

As people age, damaging molecules called lipid hydroperoxides (LOOH) may speed up muscle breakdown and lead to weakness. Researchers will use cells and animal models to test whether a scavenger drug (N-acetylcarnosine) or blocking an enzyme (LPCAT3) lowers LOOH levels and preserves muscle. They will measure muscle mass, strength, and biochemical signs of lipid damage and autophagy. The work aims to identify approaches that could be moved into human testing to help older adults keep strength and mobility.

Why it matters

Potential benefit: If successful, this work could lead to new treatments or supplements that help preserve muscle mass and mobility during aging.

How similar studies have gone: Laboratory studies support that targeting lipid peroxides can protect cells and tissues, but translating those findings into safe and effective treatments for human age-related muscle loss is still unproven.

Where this research is happening

  • Utah State Higher Education System--University of Utah
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Funai, Katsuhiko — Utah State Higher Education System--University of Utah
  • Study coordinator: Funai, Katsuhiko

Related research

Other NIH-funded projects on the same topics.

  • Therapeutic approach to reduce cellular aging and improve thigh muscle recovery after ACL injury

    A research project tests a drug (metformin) to help the thigh muscle heal better after ACL injury and reconstruction.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11450887

  • MG53 protein to protect aging muscles during disuse

    A small research project will explore whether increasing MG53 protein can help prevent muscle loss during periods of inactivity in aging, with the goal of protecting muscle health.

    NIH research University of Nebraska Lincoln · Lincoln, United States · NIH-11406337

  • Oxidized lipids driving aging-related muscle loss

    This project explores how certain lipid molecules that are damaged or modified over time contribute to muscle weakness and loss in older adults, with the goal of identifying new ways to prevent sarcopenia.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11396249

  • Role of Depp1 in muscle loss and weakness

    A study at a major hospital is exploring whether a protein called Depp1 drives muscle loss when muscles don’t get enough nutrients or oxygen, with the aim of finding ways to prevent this wasting.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11268416

  • Gut bacteria therapy for muscle wasting

    This project tests whether changing gut bacteria can help prevent or reverse muscle wasting in people with cancer-related cachexia or disuse atrophy.

    NIH research University of Kentucky · Lexington, United States · NIH-11264924

  • BNIP3 and muscle wasting in pancreatic cancer

    This work looks at whether a protein called BNIP3 drives muscle wasting in people with pancreatic cancer and whether muscle-derived blood markers could help detect cancer earlier.

    NIH research University of Chicago · Chicago, United States · NIH-11241130

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.